July 23, 2026

The lawsuit comes as Lilly has gotten the upper hand in a high-stakes battle for market share. Lilly’s medicine, Zepbound, recorded $4 billion in sales in the first quarter of 2026 compared with the 18.2 billion krone, or $2.7 billion, generated by Novo’s Wegovy. The turf war escalated this year with both companies launching obesity pills that could extend the reach of weight-loss medicines.

Bankruptcies among medical practices made up nearly 30% of all healthcare filings in the first half of 2026, putting the sector on pace to reach its highest level of bankruptcies since 2019.

CMS proposed new limits on provider and managed care taxes that states use to finance Medicaid, implementing provisions of the GOP’s “Big Beautiful Bill” and potentially reducing federal Medicaid spending by $246 billion over 10 years. The changes would tighten oversight and phase down allowable tax thresholds, which providers and states warn could reduce Medicaid funding, strain safety-net providers, and contribute to coverage losses.

Clover Health disclosed a data breach after hackers used social engineering to access three employees’ accounts, potentially exposing members’ personal and protected health information. The insurer has contained the breach and is investigating, but has not yet determined what data was accessed or how many members may be affected.

This article highlights the ongoing legal and regulatory uncertainty surrounding Medicare Advantage Star Ratings and underscores the potential financial and policy implications of future court decisions for both CMS and MA insurers.